Duration of IOP Reduction With Travoprost BAK-free Solution-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Duration of IOP Reduction With Travoprost BAK-free Solution

Published:2008-04 Issue:3 Volume:17 Page:217-222
ISSN:1057-0829
Container-title:Journal of Glaucoma
language:en
Short-container-title:

Author:

Gross Ronald L.,Peace James H.,Smith Stephen E.,Walters Thomas R.,Dubiner Harvey B.,Weiss Mark J.,Ochsner Katherine I.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology

Reference20 articles.

1. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile;Broadway;Arch Ophthalmol,1994

2. Corneal and conjunctival changes caused by commonly used glaucoma medications;Noecker;Cornea,2004

3. Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol;Goto;Arch Ophthalmol,2003

4. Evaluation of the comfort of Alphagan P compared to Alphagan in irritated eyes;Mundorf;Adv Ther,2003

5. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication;Pisella;Br J Ophthalmol,2002

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preservative-Free Bimatoprost 0.01% Ophthalmic Gel for Glaucoma Therapy: A Phase III Randomized Controlled Trial;Journal of Glaucoma;2024-03-04

2. COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan®) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT);Expert Opinion on Drug Safety;2023-09-06

3. Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus Statement;American Journal of Ophthalmology;2022-09

4. Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial;Scientific Reports;2021-07-22

5. Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops;Cutaneous and Ocular Toxicology;2020-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3